Previous / Next

[20120308. Complications of EMR/ESD (63): Bleeding (27) - aspirin (7) evidence based approach]

Bleeding after ESD. 2022-10-16. 이준행

American College of Chest Physicians에서 증거기반 가이드라인을 냈습니다 (Chest 2012). 그 중 아스피린 관련 내용을 옮깁니다.

1. In moderate- to high-risk patients who are receiving acetylsalicylic acid (ASA) and require noncardiac surgery, we suggest continuing ASA around the time of surgery instead of stopping ASA 7 to 10 days before surgery (Grade 2C).

2. In patients with a coronary stent who require surgery, we recommend deferring surgery > 6 weeks after bare-metal stent placement and > 6 months after drug-eluting stent placement instead of undertaking surgery within these time periods (Grade 1C).

3. In patients requiring surgery within 6 weeks of bare-metal stent placement or within 6 months of drug-eluting stent placement, we suggest continuing antiplatelet therapy perioperatively instead of stopping therapy 7 to 10 days before surgery (Grade 2C).

역시 마찬가지입니다. 가급적 끊지 말라고 하는군요.

[참고 자료]

1) EndoTODAY 와파린

2) 항혈소판제 Antiplatelets - 내시경 혹은 조직검사 전 아스피린, 항혈소판제를 끊을 것인가?

3) 새로운 항응고제 New oral anticoagulant (NOAC)

4) 항혈소판제, 항응고제 중단 지침 (삼성서울병원 2011)

© 일원내시경교실 바른내시경연구소 이준행